ARCHIVES

Lenalidomide, An Altered Thalidomide, Shows Promise

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | November 24, 2006

Download PDF Visit The Full Archive

Related Articles

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them

May 16, 1975

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Magnson Makes It Clear Senate Will Add Substantial Sums To Budget, Objects To Training Grant Phaseout

May 17, 1974